| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/01/1994 | CN1087347A Novel sulfonamide inhibitors of aspartyl protease |
| 05/31/1994 | US5317272 Process and apparatus employing a stream of electrolytic liquid for examining the porosity of coated objects |
| 05/31/1994 | US5317252 Dosimeter for monitoring the condition of polymeric materials and chemical fluids |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/31/1994 | US5316953 Determining risk of fetal Down syndrome |
| 05/31/1994 | US5316952 Blood sample apparatus and method |
| 05/31/1994 | US5316951 Method for the improved determination of white blood cell subpopulations |
| 05/31/1994 | US5316950 Method for quantitative calibration of in situ optical chemical measurements in soils using soil class and characteristics |
| 05/31/1994 | US5316936 Fixing sheep erythrocytes, mixing albumin and chromium chloride and detection of antigens |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316922 Binding proteins, ligation polynucleotides and insertion gene coding |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316918 Method and apparatus for testing MAI (mycobacterium avium-intracellulare) for antimicrobial agent sensitivity |
| 05/31/1994 | US5316916 High-density lipoprotein solid-base assay device |
| 05/31/1994 | US5316915 Method for the determination of antibodies against lipocortins |
| 05/31/1994 | US5316914 Method for determining human collagen peptides by way of enzyme immunoassay |
| 05/31/1994 | US5316913 Neutrophil LECAM-1 as indicator of neutrophil activation |
| 05/31/1994 | US5316912 Polyacrylic hydrazides and their applications as glycoprotein reagents |
| 05/31/1994 | US5316911 Method of determining the presence of endotoxin in a sample |
| 05/31/1994 | US5316909 Quantitative analysis |
| 05/31/1994 | US5316784 Process for the production of a solid phase matrix coated with an immunologically active substance |
| 05/31/1994 | US5316754 In vitro assay of mesangial cell-derived receptors for advanced glycosylation endproducts |
| 05/31/1994 | US5316731 Container used for testing for the presence of microorganisms in blood |
| 05/31/1994 | US5316730 Disposable cartridge for investigating physical properties of blood |
| 05/31/1994 | US5316725 Separation by particle size |
| 05/31/1994 | US5316647 Portable oxygen analyzer |
| 05/31/1994 | CA2018858C Optical read head for immunoassay instrument |
| 05/28/1994 | CA2110141A1 Oligonucleotides of hcv, primers and probes therefrom, method of determining hcv genotypes, and method of detecting hcv in samples |
| 05/28/1994 | CA2108826A1 Fluorescence method of quantifying hydrocarbons, including crude oil, dispersed in water |
| 05/26/1994 | WO1994011831A1 Modular microprocessor-based health monitoring system |
| 05/26/1994 | WO1994011752A1 Functional radar warning receiver back-up generator |
| 05/26/1994 | WO1994011740A1 Detection of anti-hpa antibodies |
| 05/26/1994 | WO1994011739A1 Diagnosis of eye disorders |
| 05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
| 05/26/1994 | WO1994011737A1 Method for detection of a new marker associated with hepatitis delta virus infection |
| 05/26/1994 | WO1994011736A1 Immunoassays for antibodies in urine to microorganisms associated with sexually transmitted diseases |
| 05/26/1994 | WO1994011735A1 Method and apparatus for bioaffinity assays |
| 05/26/1994 | WO1994011734A1 Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand |
| 05/26/1994 | WO1994011733A1 System for measuring metabolic gas emissions from animals |
| 05/26/1994 | WO1994011732A1 Calibration systems |
| 05/26/1994 | WO1994011533A1 METHODS FOR DETERMINING THE PRESENCE OF FUNCTIONAL p53 IN MAMMALIAN CELLS |
| 05/26/1994 | WO1994011531A1 Identification of neoplasms by detection of genetic insertions and deletions |
| 05/26/1994 | WO1994011530A1 Positional sequencing by hybridization |
| 05/26/1994 | WO1994011527A1 Multiple coagulation test device and method |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011500A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011490A2 Products of the inhibition of advanced glycosylation |
| 05/26/1994 | WO1994011466A1 Anilines as marking agents for mineral oils |
| 05/26/1994 | WO1994011421A1 A method of surface modification |
| 05/26/1994 | WO1994011405A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | WO1994011404A1 Antibodies for gm-csf receptor and uses thereof |
| 05/26/1994 | WO1994011403A1 Artificial antibodies, method of producing the same and use thereof |
| 05/26/1994 | WO1994011401A1 Human homolog of the e-cadherin gene and methods based thereon |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994011348A1 Detection of hypoxia |
| 05/26/1994 | WO1994011305A1 Separation of nucleic acid fragments |
| 05/26/1994 | WO1994011107A1 Device for collection and processing of biological samples |
| 05/26/1994 | WO1994011103A1 Magnetic solid phase supports |
| 05/26/1994 | WO1994011078A1 Magnetic immobilization and manipulation of biological entities |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994010901A1 Process and device for glucose determination in a biological matrix |
| 05/26/1994 | WO1994009805A3 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
| 05/26/1994 | DE4305593C1 Drug detection test system - comprises ampoule contg. colour indicator and fine non-porous carrier particles |
| 05/26/1994 | DE4239377A1 Determining viscosity and reactivity of coating resin cured by UV - by instrument which irradiates drop of resin under controlled conditions, measures viscosity with e.g. Searle viscometer, and plots readings |
| 05/26/1994 | DE4239221A1 Ultrasonic reflectometry for flaw detection in reinforced concrete - compares backscatter measurements over constant distance along and across line of crack during successive phases of test |
| 05/26/1994 | DE4238994A1 Aniline als Markierungsmittel für Mineralöle Anilines as markers for mineral oils |
| 05/26/1994 | DE4238989A1 Soil sampling device - has sample cutting frame equipped with turn-over device |
| 05/26/1994 | DE4238967A1 Measuring redox potentials due to radical effective changes of redox properties - using electrolyte capillary in which lower part of reference electrode, i.e. polished diaphragm, projects |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149911A1 Calibration systems |
| 05/26/1994 | CA2149881A1 Antibodies for gm-csf receptor and uses thereof |
| 05/26/1994 | CA2149747A1 Anilines as marking agents for mineral oils |
| 05/26/1994 | CA2149642A1 Immunoassays for antibodies in urine to microorganisms associated with sexually transmitted diseases |
| 05/26/1994 | CA2149318A1 Identification of neoplasms by detection of genetic insertions and deletions |
| 05/26/1994 | CA2149056A1 Novel polypeptides with opioid receptor activity, nucleic acids encoding these substances and uses thereof |
| 05/26/1994 | CA2149043A1 Artificial antibodies, method of producing the same and use thereof |
| 05/26/1994 | CA2148817A1 Multiple coagulation test device and method |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/26/1994 | CA2126690A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | CA2109855A1 Base dissociation assay |
| 05/25/1994 | EP0598663A2 A pretreatment method for blood analysis |
| 05/25/1994 | EP0598644A1 Capillary rheometer plunger pressure transducer and measurement technique |
| 05/25/1994 | EP0598620A2 An analytical system or kit for phosphatase |
| 05/25/1994 | EP0598460A2 Method for analysing substances and measuring cell for carrying out the method |
| 05/25/1994 | EP0598341A1 Optical sensor for detecting chemical species |
| 05/25/1994 | EP0598340A1 Polymer films for detecting chemical substances |
| 05/25/1994 | EP0598329A2 Simultaneous determination of HbA1c and haemoglobin variants with a HbA1c analog glycation |
| 05/25/1994 | EP0598262A2 Breath-sampling device for measuring breath component levels |
| 05/25/1994 | EP0598127A1 Method and apparatus for analyzing physical quantities, and apparatus for removing line spectrum noise |
| 05/25/1994 | EP0598108A1 Rabbit single domain antibody and use thereof |
| 05/25/1994 | EP0598003A1 Substrate for surface-enhanced analytical procedures, and substrates prepared for specific procedures |
| 05/25/1994 | EP0598000A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 05/25/1994 | EP0597984A1 Device for detecting aqueous contaminants |
| 05/25/1994 | EP0597951A1 An assay with signal detection in the presence of a suspended solid support |